Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens
Gretchen M. Hill, George J. Brewer, Ananda S. Prasad, Connie R. Hydrick, Deborah E. Hartmann – 1 May 1987 – The standard therapy for preventing copper accumulation in Wilson's disease, D‐penicillamine, has been a life‐saving drug, but it has many side effects and some patients are completely intolerant. We have been using oral zinc as another approach to the therapy for Wilson's disease, with copper balance studies as the key initial assessment of the adequacy of a given dose or regimen of zinc therapy.